Volk et al. reported that PIVKA-II is superior to either AFP or AFP-L3% at differentiating between HCC and cirrhosis (sensitivity 86%, specificity 93%), but that the AUC is lower for patients with high-risk HCC vs. low-risk HCC [34]. Here, AFP is linked to Cirrhosis.